Thymidine phosphorylase gene variant, platelet counts and survival in gastrointestinal cancer patients treated by fluoropyrimidines.
Thymidine phosphorylase gene variant, platelet counts and survival in gastrointestinal cancer patients treated by fluoropyrimidines.
复制标题
DOI:
10.1038/srep05697
复制
发表时间:
2014-07-16
影响因子:
4.6
通讯作者:
Yuan X
中科院分区:
文献类型:
--
作者:
Huang L;Chen F;Chen Y;Yang X;Xu S;Ge S;Fu S;Chao T;Yu Q;Liao X;Hu G;Zhang P;Yuan X
The predictive value of thymidine phosphorylase gene variants (TP, also called platelet-derived endothelial cell growth factor) and thrombocytosis were controversial and worthy of further study in gastrointestinal cancer (GIC) patients. We screened all of the common missense single nucleotide polymorphisms (MAF ≥ 0.1) in fluoropyrimidines (FU) pathway genes (including TP, TS, ENOSF1 and DPD). Three of them were selected and genotyped using Sequenom MassARRAY in 141 GIC patients. TP expression was assessed by immunohistochemistry. Our aim was to evaluate the prognostic significance of studied genes and platelet counts in GIC patients. Multivariate analyses indicated in rs11479-T allele carriers, platelet counts negatively correlated to overall survival. In addition, T allele of TP: rs11479 was associated with higher TP expression in cancer tissues. We suggest TP: rs11479 variant combined with platelet counts may be useful prognostic makers in GIC patients receiving first-line FU chemotherapy and thrombopoietin factor should be used with caution in the rs11479 T allele bearing patients.
登录
查看更多内容
影响因子:
45.3
作者:
Meropol, Neal J.;Gold, Philip J.;Schwarting, Roland
通讯作者:
Schwarting, Roland
影响因子:
3.7
作者:
Jennings BA;Loke YK;Skinner J;Keane M;Chu GS;Turner R;Epurescu D;Barrett A;Willis G
通讯作者:
Willis G
影响因子:
50.5
作者:
Köhne, CH;Cunningham, D;Hecker, H
通讯作者:
Hecker, H
影响因子:
3
作者:
Farina-Sarasqueta, Arantza;van Lijnschoten, Gesina;van den Brule, Adriaan J. C.
通讯作者:
van den Brule, Adriaan J. C.
影响因子:
15.3
作者:
Nyasavajjala, Sitaramachandra Murthy;Runau, Francois;Lund, Jonathan N.
通讯作者:
Lund, Jonathan N.